Bunge Limited (BG) Stock Price & How to Invest

Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It sits among the "ABCD" grain traders (ADM, Bunge, Cargill, Louis Dreyfus) and reports across three segments: Agribusiness (high-volume, low-margin oilseed processing and grain merchandising), Refined and Specialty Oils, and Milling. In July 2025 Bunge closed its roughly $8 billion merger with Glencore-backed Viterra, combining the top oilseed processor with a leading grain trader to form a group valued near $25 billion, and it sold its North American corn milling business the same month.

The investment picture is one of scale plus cyclicality. Trailing revenue has jumped to roughly $70 billion as Viterra consolidates, but profitability is driven by the crush spread (the gap between soybean meal and oil prices and the cost of raw soybeans), which swings with harvests, biofuel demand, and trade policy. After a down year in 2024 and softer 2025, analysts model an earnings recovery in 2026 and 2027 as Viterra synergies and a broader footprint kick in, but the payoff depends on integration execution and a commodity backdrop Bunge does not control.

Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the added debt and scale raise the stakes if the cycle turns. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock even after its strong run.

9 analysts publish price targets on BG, averaging $141.22 against a $106.23 price as of August 2026, or +32.9%. The published targets run from $116.00 to $150.00, a narrow spread, and the ratings split 8 buy, 1 hold, 0 sell. Over the last six months there have been 5 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BG forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Bunge Limited. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Viterra merger scale and synergies. The completed Viterra combination roughly doubles Bunge's trailing revenue base toward $70 billion and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. The most optimistic published target, $150.00, assumes this works close to its best case.

The case against. Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. The most pessimistic target, $116.00, is roughly what BG is worth if this bites instead.

Read the full bull and bear case on BG, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Bunge Limited's investor relations page or your broker.

• Revenue (TTM): ~$70 billion
• Net income (TTM): ~$0.8 billion
• Market cap: ~$24 billion
• Adjusted EPS (FY2025): ~$7.57
• P/E (trailing / forward): ~25x / ~15x
• Dividend yield: ~3%

Trailing revenue jumped toward $70 billion as the Viterra merger consolidates, while net income of roughly $0.8 billion reflects a softer commodity-margin year. The gap between the trailing P/E near 25x and a forward P/E near 15x captures the market's expectation of an earnings recovery in 2026 as Viterra contributes and crush margins normalize. Figures are approximate and move with the underlying commodity cycle.

If you want BG exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to BG: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BG exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (MOO), which spreads the position across many companies. Or build it into a focused thematic portfolio, so BG sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BG fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BG is a scaled, cash-generative agribusiness whose earnings ride commodity crush margins and the Viterra integration, which is exactly why the picture is opportunity and cyclicality in equal measure.

Whether BG is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BG a buy or a sell?, and where the stock could go from here in the BG stock forecast.

For income investors, whether BG pays a dividend and how the payout looks is covered in does BG pay a dividend? And to weigh BG against a peer, read the full side-by-side comparisons: BG vs ADM and BG vs CTVA.